Registered entities
ORAGENICS INC
Reg. No. 1174940United States
Oragenics, Inc
Reg. No. 59-3410522United States
Innovation
16 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 804 times.
| Year | Filings |
|---|---|
| 2012 | 8 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Social engagement
Social engagement: 1.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 20% |
| Other / undisclosed | 4 | 80% |
Recent activity
30 Jun 2026
Milestone
regulatory
17 Jun 2026
Product launch
intranasal platform
15 Jun 2026
Product launch
ONP-002
